scispace - formally typeset
Z

Zhiao Shi

Researcher at Baylor College of Medicine

Publications - Ā 43
Citations - Ā 9843

Zhiao Shi is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Proteogenomics & Proteomics. The author has an hindex of 27, co-authored 41 publications receiving 6563 citations. Previous affiliations of Zhiao Shi include University of Tennessee & University Of Tennessee System.

Papers
More filters
Journal ArticleDOI

WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs.

TL;DR: In the 2019 update, WebGestalt supports 12 organisms, 342 gene identifiers and 155 175 functional categories, as well as user-uploaded functional databases and has completely redesigned result visualizations and user interfaces to improve user-friendliness and to provide multiple types of interactive and publication-ready figures.
Journal ArticleDOI

WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013

TL;DR: By integrating functional categories derived from centrally and publicly curated databases as well as computational analyses, WebGestalt has significantly increased the coverage of functional categories in various biological contexts, leading to a total of 78 612 functional categories.
Journal ArticleDOI

Proteogenomic characterization of human colon and rectal cancer

Bing Zhang, +64 more
- 18 SepĀ 2014Ā -Ā 
TL;DR: Integrated proteogenomic analysis provides functional context to interpret genomic abnormalities and affords a new paradigm for understanding cancer biology.
Journal ArticleDOI

WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit

TL;DR: Gene Set Enrichment Analysis and Network Topology-based Analysis have been added to WebGestalt 2017, providing complementary approaches to the interpretation of high-throughput omics data.
Journal ArticleDOI

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

TL;DR: A view of how the somatic genome drives the cancer proteome and associations between protein and post-translational modification levels and clinical outcomes in HGSC is provided.